Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
09 juin 2017 08h07 HE
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
CHF Solutions’ Aquadex Flexflow® Ultrafiltration System Featured in the May 2017 Journal of The American College of Cardiology Review of Ultrafiltration as a Promising Treatment for Fluid Overload Associated with Heart Failure
05 juin 2017 07h00 HE
|
CHF Solutions
EDEN PRAIRIE, Minn., June 05, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that clinical trials using its Aquadex FlexFlow® Ultrafiltration...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
09 mai 2017 09h33 HE
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
Sunshine Heart hires Jim Breidenstein as Chief Commercial Officer
11 avr. 2017 06h00 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., April 11, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that on April 24, 2017, Jim Breidenstein will join the Company as Chief Commercial...
Sunshine Heart Receives Nasdaq Listing Extension
29 mars 2017 06h00 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., March 29, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for...
First-Ever Presentation on Abiomed’s Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific Session
19 mars 2017 14h30 HE
|
Abiomed
- Real-World Data Representing 15,259 Patients WASHINGTON, March 19, 2017 (GLOBE NEWSWIRE) -- Data from Abiomed’s (NASDAQ:ABMD) Impella® Quality (IQ) Assurance Program, which includes the IQ...
Abiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations
16 mars 2017 08h00 HE
|
Abiomed
DANVERS, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 10...
New Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
09 mars 2017 08h00 HE
|
Abiomed
DANVERS, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- A new study published in Circulation Research finds use of hemodynamic support with Impella® 2.5 heart pump during high-risk percutaneous coronary...
Sunshine Heart to Partner with the American Association of Heart Failure Nurses
27 févr. 2017 05h00 HE
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that the company will partner with the American Association of Heart Failure Nurses...
Abiomed Surpasses 50,000 Impella® Patients Treated in the United States
23 févr. 2017 14h00 HE
|
Abiomed
DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced that it has supported more than 50,000...